Assessing Cognitive Safety and Tolerability in Drug Trials

Aug 16, 2016

According to this article from Charlotte Housden, Head of the Biotechnology and Research Business Unit at Cambridge Cognition, there is increasing pressure on pharmaceutical companies to accelerate the development of safe and effective treatments whilst reducing the risk of failure ...

Read More